Correspondence 0001213900-23-047065 from ABVC BIOPHARMA, INC. (ABVC) (CIK 0001173313) (ABVC)
ABVC BIOPHARMA, INC. (ABVC) (CIK 0001173313)
Date: June 7, 2023 · CIK: 0001173313 · Accession: 0001213900-23-047065
AI Filing Summary & Sentiment
File numbers found in text: 333-271416
Letter
ABVC BioPharma, Inc.
44370 Old Warm Springs Blvd.,
Fremont, CA 94538
VIA EDGAR
June 7, 2023
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 3561
Washington, D.C. 20549
Attn: Mr. Tyler Howes
Re: ABVC BioPharma, Inc.
Amendment to Registration Statement on Form S-1, as amended (File No. 333-271416)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, ABVC BioPharma Inc., a Nevada corporation (the “Company”), hereby requests that the effective date of the above-referenced registration statement on Form S-1, as amended, be accelerated so that it will become effective at 11:00 a.m. Eastern Time on June 8, 2023 or as soon thereafter as practicable.
Very truly yours,
/s/ Howard Doong
Show Raw Text
CORRESP
1
filename1.htm
ABVC BioPharma, Inc.
44370 Old Warm Springs Blvd.,
Fremont, CA 94538
VIA EDGAR
June 7, 2023
U.S. Securities
and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 3561
Washington, D.C. 20549
Attn: Mr. Tyler Howes
Re:
ABVC BioPharma, Inc.
Amendment to Registration Statement on Form S-1, as amended (File No. 333-271416)
Ladies and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, ABVC BioPharma Inc., a Nevada corporation (the “Company”),
hereby requests that the effective date of the above-referenced registration statement on Form S-1, as amended, be accelerated so that
it will become effective at 11:00 a.m. Eastern Time on June 8, 2023 or as soon thereafter as practicable.
Very truly yours,
/s/ Howard Doong
Howard Doong
Chief Executive Officer